The first international ecancer conference on oncology and radiotherapy happened in

The first international ecancer conference on oncology and radiotherapy happened in Santiago de Chile on 6 and 7 May 2016. in the subject and the undoubtable merit of the guest instructors. For the opening ceremony we were honoured with the presence of Professor Gordon McVie Founder of ecancer Dr Beatriz Amendola President of the symposium and Dr Jorge Jimenez President of Foro Nacional de Cancer Chile and former Minister of Health. Keywords: symposium cancer surgery radiotherapy eCountouring radio-surgery oncology This conference constitutes NVP-BGJ398 ecancer’s first conference dedicated specifically to radiotherapy. Many scientific modules had been carried out through the entire conference with the purpose of dealing with and updating the city on radiotherapy signs in malignancies that are most common in Latin America. The modules dealt with the next topics: lung tumor breast cancers gynaecologic tumor and tumor of the top and throat. The themes had been presented inside a multidisciplinary way all the pillars mixed up in treatment of tumor were included such as for example operation radiotherapy and medical oncology. We also utilized the opportunity to talk about through satellite sessions the existing position of radiotherapy in Latin America and providing participants the chance to interact and evaluate fresh emerging systems with market symposia. An ‘eContouring’ program NVP-BGJ398 was conducted supported by Varian Medical Systems and EduCase as well as ASTRO (American Society for Radiation Oncology). This event was held in high regard by the community of NVP-BGJ398 oncology professionals in Chile as it allowed for a NVP-BGJ398 multidisciplinary focus such as medical procedures radiotherapy and chemotherapy in the management of patients with cancer. It is important to highlight that in Keratin 10 antibody Latin American countries the studies are carried out in a manner that are relatively isolated from the rest of the community which is particularly different to what occurs in the rest of the world specifically Europe where research is usually carried out in a coordinated fashion within the different countries experiences and findings are shared and no boundaries are present to set back the medical progress in this part of the world. For this reason contributions such as the courses provided by ecancer are fundamental to the extinction of these barriers and the emergence of a more team-guided effort to research. The principal objective of this conference was to demonstrate multidisciplinary cooperation in analysing the different pathologies. With the use of more modern technologies and equipment considering the pros and cons of each specific one the individual experiences of the correspondents their case-by-case interpretation the potential practical problems and how to approach them. In the lung cancer module Dr Andres Córdova President of the Radiotherapy Society of Chile emphasised the importance of tobacco consumption in the appearance of this cancer and called to attention the high prevalence of tobacco consumption in Chile. In addition Dr Córdova exhibited the superiority of pre-screening for prevention with low-dosage TAC in relation to radiography of the thorax in high-risk populations emphasising the importance of prevention. Subsequently Dr Claudio Suarez thoracic surgeon of Santa Maria de Santiago Clinic discussed the different types of surgical interventions their advantages and disadvantages as well as how a good programme for early detection can greatly improve the statistics for survival. Dr Beatriz Amendola of the ‘Innovative Cancer Institute’ Miami EEUU presented lectures in NVP-BGJ398 relation to radiosurgery in general and the management of metastasis in lung cancer. Dr Amendola emphasised the increase in the incidence and negative results of treatment in cases of late detection. It was exhibited how stereotactic body radiation therapy (SBRT) has been gaining prevalence specifically in elderly patients or those patients presenting comorbidities that present an impediment to surgical intervention. With regards to the treatment NVP-BGJ398 of metastasis the importance of SBRT in vertebral hepatic and cerebral metastasis and the associated subdivisions was exhibited. Dr Lus E Raez of the Memorial Cancer Institute.